[GENERAL PRINCIPLES IN THE DRUG THERAPY OF CEREBROVASCULAR DISORDERS].
D000255:Adenosine Triphosphate; D000305:Adrenal Cortex Hormones; D000959:Antihypertensive Agents; D001775:Blood Circulation; D002561:Cerebrovascular Disorders; D002740:Chlorothiazide; D003580:Cytochromes; D006801:Humans; D006830:Hydralazine; D007610:Kallikreins; D008750:Methyldopa; D008996:Monoamine Oxidase Inhibitors; D009525:Niacin; D011239:Prednisolone; D012110:Reserpine; D014665:Vasodilator Agents
D000305:Adrenal Cortex Hormones; D000959:Antihypertensive Agents; D003580:Cytochromes; D008996:Monoamine Oxidase Inhibitors; D014665:Vasodilator Agents; D009525:Niacin; D006830:Hydralazine; D008750:Methyldopa; D002740:Chlorothiazide; D012110:Reserpine; D000255:Adenosine Triphosphate; D011239:Prednisolone; D007610:Kallikreins
ADENOSINE TRIPHOSPHATE; ADRENAL CORTEX HORMONES; ANTIHYPERTENSIVE AGENTS; BLOOD CIRCULATION; CEREBROVASCULAR DISORDERS; CHLOROTHIAZIDE; CYTOCHROMES; HYDRALAZINE; KALLIKREIN; METHYLDOPA; MONOAMINE OXIDASE INHIBITORS; NICOTINIC ACID; PREDNISOLONE; RESERPINE; REVIEW; VASODILATOR AGENTS